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Objective. This study examines the eﬀects of iron ions Fe3+ on the respiratory burst of phagocytes isolated from peritoneal eﬄuents
of continuous ambulatory peritoneal dialysis (CAPD) patients, as an in vitro model of iron overload in end-stage renal disease
(ESRD). Material and Methods. Respiratory burst of peritoneal phagocytes was measured by chemiluminescence method. Results.
At the highest used concentration of iron ions Fe3+ (100µM), free radicals production by peritoneal phagocytes was reduced by
90% compared to control. Conclusions. Iron overload may increase the risk of infectious complications in ESRD patients.
1.Introduction
Anemia is a common complication of end-stage renal di-
sease (ESRD) and results from decreased erythropoietin
(EPO) production, reduced bone marrow response to EPO,
shortened red blood cell survival, and chronic iron loss.
Anemia can be treated by administration of erythropoiesis-
stimulating agents, that is, EPO [1].
TheeﬃcacyofEPOtreatmentindialysispatientsisdeter-
mined mainly by the availability of iron [2]. Hence, intra-
venous iron supplementation is recommended in ESRD
patients to support erythropoiesis [3]. However, iron supple-
mentation can cause iron overload, occurring typically when
the plasma iron content exceeds the iron-binding capacity
of transferrin. Iron overload can also be a consequence of
increased erythrocyte destruction [4].
Iron and its binding proteins have immunoregulatory
properties, and altering the balances in immune system by
iron overload or deﬁciency may produce detrimental physi-
ological eﬀects [5]. As infection contributes greatly to mor-
tality and morbidity in ESRD patients [6], the potential for
iron therapy to impair immune system and thus to increase
the risk of infection deserves special consideration.
Reactive oxygen species produced by phagocytic leuko-
cytes (macrophages, monocytes, and neutrophils) play a pri-
mary role in antimicrobial defense of the host. Phagocytosis
of bacteria, viruses, and so forth is accompanied by a sharp
increase in oxygen uptake, a process known as “respiratory
burst,” resulting in the production of the toxic oxygen
compounds, that is, H2O2, hydroxyl radical, and superoxide
anion, which kill phagocyted microorganisms [7].
The aim of the study was to investigate in vitro the eﬀects
of iron ions Fe3+ on the respiratory burst of phagocytes
isolated from peritoneal eﬄu e n t so fc o n t i n u o u sa m b u l a t o r y
peritoneal dialysis (CAPD) patients.
2. Methods
2.1. Isolation of Peritoneal Phagocytes. Peritoneal phagocytes
were obtained from CAPD patients not receiving iron and/or
EPO cotreatment and not suﬀering from any infection dur-
ing the study. Cells were isolated from peritoneal overnight
dwell time eﬄuents by centrifugation (1200×g, 10min,
4◦C), followed by removal of the contaminating erythrocytes
by hypotonic lysis. To harvest suﬃcient number of cells,
eﬄuents of ﬁve diﬀerent patients were used for obtainment
of each cell pool. Following isolation, cells were resuspended
in Krebs-Ringer buﬀer, counted, and analysed using May-
Gr¨ unwald Giemsa staining performed concomitantly with
the trypan blue exclusion viability test.2 ISRN Urology
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Figure 1: Respiratory burst of nonprimed (a) and LPS-primed (100ng/mL, 20min) (b) peritoneal phagocytes activated by latex beads
suspension (10µL). Representative time-response curves of CL intensities recorded for 60min at 37◦C in the presence (•) and absence (◦)
of latex are shown.
The study was approved by the ethics committee of
JagiellonianUniversity in Cracow, and informed consentwas
obtained from each of the patients.
2.2. Measurements of Respiratory Burst. Respiratory burst of
peritoneal phagocytes was measured using chemilumines-
cence (CL) method. Brieﬂy, cells were plated in 96-well white
plates (1.5 × 105/well) and incubated (30min, 37◦C) in
the presence or absence of urea (5–50mM), creatinine (50–
1000µM), or iron ions Fe3+ (10–100µM; as FeCl3 solution),
before addition of Krebs-Ringer buﬀer containing luminol
(5-amino-2,3-dihydro-1,4-phthalazinedione; 2.3mM) and
glucose (5mM). In the separate series of experiments, cells
were exposed for 20min to lipopolysaccharide (LPS; E.
coli 0111:B4; 100ng/mL) prior to the treatment with the
above-mentioned agents. Respiratory burst was initiated by
addition of latex beads suspension (polystyrene, 0.8µm,
3% aqueous suspension; 10µL/well). CL was measured
for 60min at 37◦C using Microlumat LB96P luminometer
(Berthold, Austria).
2.3. Statistics. All measurements were performed in tripli-
cates. Respiratory burst results are expressed as area under
curve (AUC), being the diﬀerence between time-response
curves of CL intensities recorded in the presence and absence
of latex. Results are given as mean ± SEM, calculated on
the basis of ﬁve independent experiments, each experiment
being performed on cells pooled from dialysates of ﬁve
patients. Unless indicated otherwise, statistical analyses were
performed on nonnormalized data using one-way ANOVA
followed by Tukey-Kramer multiple comparison test. IC25
and IC50 values were estimated based on interpolations of
data from concentration-response curves. ∗, ∗∗,a n d∗∗∗
indicate P<0.05, 0.01 and 0.001, respectively.
3. Results
In the present study, the eﬀects of iron ions Fe3+ on latex-
induced respiratory burst of peritoneal phagocytes were
investigated. As bacterial infection is considered as a major
complication of CAPD [8], respiratory burst was also mea-
sured in the presence of LPS, one of the most powerful bac-
terial virulence factors with proinﬂammatory properties [9].
The eﬀects of iron were compared with phagocyte response
to two classical uremic toxins, that is, urea and creatinine.
Peritoneal cell populations used in the study contained
42–52%macrophages,36–42%lymphocytes,and5–7%neu-
trophils, and their overall viability was 93–97%. The highest
respiratory burst intensities were observed for 1.5 × 105
cells/well and 10µL latex suspension/well (data not shown),
and these conditions were used in subsequent experiments.
LPS was found to be a strong primer of latex-induced
respiratory burst. Figures 1(a) and 1(b) show time-response
curves of CL for nonprimed and LPS-primed (100ng/mL,
20min) cells, respectively, with the AUC value calculated for
the primed cells being ∼2.5 × higher than in the absence of
LPS.
Iron ions Fe3+, urea, and creatinine were used at the
concentrations ranging fromphysiological to maximal (butISRN Urology 3
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Figure 2:Eﬀectsofurea((a)and(b)),creatinine((c)and(d)),andironionsFe3+ ((e)and(f))onrespiratoryburstofperitonealphagocytes.
Dose-response curves showing the intensities of respiratory burst calculated from AUC values for nonprimed ((a), (c), and (e)) and LPS-
primed (100ng/mL, 20min; (b), (d), and (f)) cells. Cells were exposed to tested agents for 30min prior to CL measurements. Results are
given as mean ± SEM relative to controls on the basis of ﬁve independent experiments.4 ISRN Urology
Table 1: IC25 and IC50 values for the eﬀects of urea, creatinine, and iron on respiratory burst of nonprimed and LPS-primed peritoneal
phagocytes.
Tested agent Used phagocytes IC25 IC50
Urea Nonprimed 18.3mM (17.3–19.5) >50mM —
LPS-Primed 6.1mM (5.3–6.9) >50mM —
Creatinine Nonprimed 973.3µM (940.1–1007.6) >1000µM—
LPS-Primed 455.3µM (444.9–465.8) >1000µM—
Iron ions Fe3+ Nonprimed 9.5mM (5.3–10.0) 34.5mM (32.8–36.2)
LPS-Primed 7.3mM (4.7–8.3) 26.8mM (26.2–27.5)
Numbers in parentheses indicate interpolated values for IC25 or IC50± SEM (based on AUC values from ﬁve independent experiments).
still observed in uremic patients). All these agents inhibited
respiratory burst of both nonprimed (Figures 2(a), 2(c),a n d
2(e)) and LPS-primed (Figures 2(b), 2(d),a n d2(f)) cells in a
concentration-dependent manner. However, the sensitivities
of the cells to tested agents were highly variable. Thus, for
nonprimed cells, the highest used concentrations of agents
caused an average reduction of respiratory burst to ∼59,
74, and 11% relative to controls, for urea, creatinine, and
iron ions Fe3+, respectively. Likewise, at the highest con-
centrations used, respiratory burst of LPS-primed cells was
most strongly reduced by iron ions Fe3+ (∼21% of control),
whereas both urea and creatinine caused milder inhibitions
(∼63 and 66% of control, resp.). Table 1 presents IC25 and
IC50 values for the estimated eﬀects of tested agents on respi-
ratory burst. Only iron ions Fe3+ exhibited the IC50 values
below the highest used concentration (100µM), for both
nonprimed and LPS-primed cells whereas all tested agents
exhibitedIC25 valueswithinemployedconcentrationranges.
4. Discussion
Achieving and maintaining iron suﬃciency is crucial for
the eﬃcacy of EPO treatment in dialysis patients [2].
Available reports on the eﬀects of iron supplementation on
immunity of ESRD patients are inconclusive. Several large-
scaleprospectivestudiesshowednorelationshipbetweenrisk
of bacteremia and iron administration [10, 11]. In contrast,
retrospective trial in hemodialysis patients reported a pos-
sible increase in infection rate associated with iron therapy
[12].Asthebiologicallyactiveironplaysanimportantrolein
the immunity [5], the controversy surrounding the eﬀects of
iron supplementation on risk of infections in ESRD patients
requires special attention.
In this study, we investigated in vitro eﬀects of iron
on respiratory burst of phagocytes obtained from CAPD
patients. Investigations were performed on both nonprimed
and LPS-primed phagocytes and compared to the eﬀects
of urea and creatinine. The lowest concentrations of urea
and creatinine used in our study reﬂected the physiological
plasma levels found in healthy subjects while middle and
the highest concentrations were within the range observed
in ESRD patients [13]. Iron was used at the concentrations
comparable with the plasma levels of non-transferrin-bound
Fe3+ in CAPD patients (10mM) or in iron overload patients
(50–100mM) [14].
Both urea and creatinine inhibited the respiratory burst
of phagocytes in a concentration-dependent manner, even
at concentrations comparable to physiological. This observa-
tionisinagreementwiththeresultsobtainedbyDanielsetal.
showing the inhibitory eﬀects of low-molecular-weight con-
stituents of peritoneal dialysis eﬄuent on respiratory burst
of PMNL in vitro [15]. The eﬀects of non-transferrin-bound
Fe3+ on respiratory burst were much more pronounced
as compared to urea and creatinine. At the highest used
concentration of iron, free radicals production by peritoneal
phagocytes was reduced by 90%.
The mechanism by which iron inhibits respiratory
burst of peritoneal phagocytes remains unclear. A possible
explanation could be peroxidation of membrane lipids
m e d i a t e db yi r o ni o n sF e 3+ as some products of lipid
peroxidation have been reported to suppress respiratory
burst of macrophages [16]. Further investigations are needed
to verify this hypothesis. Future studies should also address
the possibility of additive or synergistic interactions between
uremic toxins and iron ions Fe3+.
The results obtained in this study suggest that iron sup-
plementation can suppress respiratory burst of phagocytes.
As the iron deﬁciency can also impair immune system, care-
ful assessing of iron status in ESRD patients can be of impor-
tancetoreducetheriskofinfections.However,dataobtained
in vitro must be considered with appropriate limitations
when we try to extrapolate them directly to in vivo situation.
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